A new variant of COVID-19 affects plasma treatment, potentially reducing vaccine efficacy
JOHANNESBURG (Reuters) – The new variant of COVID-19 identified in South Africa may avoid the antibodies that attack it in treatments using blood plasma from previously recovered patients, an…
